Axogen, Inc. (NASDAQ: AXGN) has recently completed the rolling submission process for its biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®.

The origin of life required the emergence of metabolism, an autocatalytic network of enzymatic reactions that synthesize amino acids, nucleotides, and cofactors. At the origin of metabolism, there ...

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in ...

AO Advice: How Your High School is Evaluated in the College Admissions Process Get the inside scoop on how colleges assess your high school and its course rigor. Featuring a former Admissions Officer, ...

Editor’s note: You may have reached this page because you tried to access a URL on ITPro Today, Network Computing, or IoT World Today that is no longer supported. As of September 2025, these Informa ...

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the ...

Avance Technologies has signed a non-binding term sheet to acquire up to a 100 per cent equity stake in Pushpak AI, a computer vision and edge artificial intelligence platform headquartered in ...

Avance Technologies has signed a non-binding term sheet to acquire upto 100% equity stake in Pushpak AI, a Hyderabad-based Computer Vision and Edge AI platform. The announcement comes amid rapid ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...